為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

    限制級
    您即將進入之新聞內容 需滿18歲 方可瀏覽。
    根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

    《TAIPEI TIMES》 New testing policy could begin tomorrow, Chen says

    
A woman undergoes a COVID-19 nasal swab test at a temporary testing station at Taipei International Airport (Songshan airport) yesterday.
Photo: Tu Chien-jung, Taipei Times

    A woman undergoes a COVID-19 nasal swab test at a temporary testing station at Taipei International Airport (Songshan airport) yesterday. Photo: Tu Chien-jung, Taipei Times

    2022/05/25 03:00

    By Lee I-chia / Staff reporter

    The policy of using a positive COVID-19 rapid test result for diagnosis could be expanded to the public starting tomorrow, the Central Epidemic Command Center (CECC) said yesterday, as it reported 82,363 new domestic cases.

    Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, last week announced that the policy of recognizing a positive COVID-19 rapid test result, after being assessed by a doctor, as the main tool for diagnosis would eventually be expanded to include everyone and could take effect this week.

    The center has been discussing with hospitals the details of transforming their polymerase chain reaction (PCR) testing stations into “three-in-one” stations that assess people’s rapid tests and prescribe drugs if needed, while offering some PCR testing capacity, Chen said.

    The time it takes for doctors to confirm a person’s test and prescribe drugs would take longer than to perform a PCR nasal swab, so patient flow and related details are still being discussed, but if the preparations are completed, the center could announce expanding the policy to the public tomorrow, he said.

    The policy would accelerate the process of COVID-19 diagnosis and enable people to start taking drugs earlier, Chen said, adding that 7,431 courses of antivirals were prescribed on Monday, including 5,680 courses of Paxlovid and 1,571 courses of molnupiravir.

    Meanwhile, Centers for Disease Control (CDC) Director-General Chou Jih-haw (周志浩), head of the CECC’s disease surveillance division, said 72 imported cases were also reported yesterday.

    CDC Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, said the peak of the local outbreak is expected to fall between late this month and early next month, but as eliminating the virus is impossible, case numbers could still fluctuate.

    Asked why the daily case count has not reached the peak of more than 100,000 estimated by the center, Chen said the trend has been relatively steady in the past few days, but he believes the numbers would increase in the next week.

    He said although many of the COVID-19 restrictions have been relaxed, people are taking preventive measures on their own.

    Passenger flow on public transport dropped 60 percent during the level 3 COVID-19 alert last year, and it has declined 45 percent this month, Chuang said.

    CDC Deputy Director-General Philip Lo (羅一鈞), deputy head of the CECC’s medical response division, said that of the 42 deaths confirmed yesterday, 39 people had underlying health conditions.

    Sixteen people had been unvaccinated, while 26, or 62 percent, did not get a booster shot.

    He said the deaths include a man in his 20s who had a nervous system disease and did not get vaccinated.

    Another was a 10-year-old who died of acute encephalitis and multiple organ failure.

    The nation’s first, second and booster dose vaccination rates were 86.94 percent, 81.41 percent and 64.41 percent respectively as of Monday, Chen said.

    新聞來源:TAIPEI TIMES

    
An employee sorts herbal medicine sachets used in traditional Chinese medicine against COVID-19 at a store in Keelung on Friday.
Photo: Cheng I-Hwa, Bloomberg

    An employee sorts herbal medicine sachets used in traditional Chinese medicine against COVID-19 at a store in Keelung on Friday. Photo: Cheng I-Hwa, Bloomberg

    不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

    焦點今日熱門

    網友回應

    此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。